Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. develops drug delivery and consumer-product dosing, dispensing and protection technologies for pharmaceutical, beauty, food, beverage, personal care and home care markets. News about ATR commonly covers operating results across Pharma, Beauty and Closures, demand trends in prescription drug delivery, biologics, injectables, nasal delivery, fragrance dispensing and closure applications.
Company updates also include product introductions such as inverted lidless dispensing closures using SimpliSqueeze® valve technology, Aptar Pharma delivery systems used in clinical-stage nasal therapies, Aptar Digital Health partnerships, dividend declarations, share repurchases and investor presentations.
Aptar (NYSE: ATR) declared a quarterly cash dividend of $0.48 per share, payable on August 20, 2026 to shareholders of record on July 30, 2026. The company will also host a one-hour webcast conference call on July 31, 2026 to discuss its second-quarter 2026 results.
Aptar (NYSE: ATR) announced that it has been named one of America’s Best Companies 2026 by TIME, ranking 83rd out of 1,000 companies evaluated with Statista. Aptar is also in the top five within the Engineering, Manufacturing and Medical Technology category and in the top 10 nationwide for sustainability transparency.
According to Aptar, the TIME list assessed companies on employee satisfaction, financial performance and sustainability transparency. The company highlighted additional 2026 sustainability recognitions, including a Gold EcoVadis ranking placing it in the top 5% of rated companies, and being named a CDP Supplier Engagement Leader for the sixth consecutive year.
Aptar’s 2025 Corporate Sustainability Report notes that, as of year-end 2025, 98% of its electricity was sourced from renewable sources, supported by power purchase agreements in Europe and North America.
Aptar (NYSE: ATR) released its 2025 Corporate Sustainability Report, Progress in Motion, covering activities from January 1 to December 31, 2025. The strategy centers on three pillars: Care, Collaboration and Circularity.
Key highlights include 98% of electricity sourced from renewables at year-end 2025, completion of a CSRD-aligned double materiality assessment, continued employee and community support programs, and ongoing innovation toward more sustainable products. The report follows GRI Standards and selected environmental and safety metrics received external assurance from ERM CVS.
Aptar (NYSE: ATR) has been named a CDP Supplier Engagement Leader for the sixth consecutive year, based on the 2025 CDP reporting cycle. The company received an “A” score on CDP’s Supplier Engagement Assessment, reflecting its climate-focused collaboration with suppliers across its value chain.
Aptar reports that over 90% of its emissions are Scope 3, with more than 80% tied to purchased goods and services, mainly raw materials like plastics. Its purchasing teams work with suppliers on lower-carbon alternatives, circularity, data sharing, and participation in sustainability assessments and initiatives.
Aptar (NYSE:ATR) will participate in two upcoming investor conferences. Executive Vice President and CFO Vanessa Kanu will present at the Jefferies Global Healthcare Conference in New York on June 3, 2026 at 12:45 p.m. ET and at the Wells Fargo Industrials and Materials Conference in Chicago on June 9, 2026 at 1:45 p.m. ET. A live audio webcast and presentation materials will be accessible in the Investors section of Aptar’s website.
Aptar (NYSE: ATR) announced a patented, reloadable airless packaging solution developed with Clarins for Total Eye Lift, claiming a 73% reduction in material impact per reload (50% less metal, 33% less plastic, 29% less cardboard). The Gaïa technology won a 2026 DIELINE award and is protected by two patents.
The design pairs a premium metal casing with plastic reloads to preserve formula protection, dispensing precision and luxury aesthetics while supporting product circularity and material efficiency.
Aptar (NYSE:ATR) reported Q1 2026 sales of $982.9M, up 11% year-over-year, with core sales flat. Reported net income was $73M and reported EPS $1.12; adjusted EPS was $1.19. Adjusted EBITDA margin was 19.2%. Returned $131M to shareholders. New CEO appointment effective September 1, 2026.
Segment strength included Beauty (+19%) and Injectables (+20%); Pharma core sales declined 1% with prescription dispensing down 10% due to emergency medicine destocking. Q2 adjusted EPS guidance: $1.32–$1.40.
Aptar (NYSE:ATR) launched an inverted lidless dispensing closure family for beauty and personal care on April 27, 2026, featuring its patented SimpliSqueeze® flow-control valve.
The design enables inverted, single-handed dispensing without a separate lid, aims to reduce drips and waste, and is already used on a pet shampoo line with extensions into home and hair care.
Aptar (NYSE: ATR) declared a quarterly cash dividend of $0.48 per share. The dividend is payable on May 27, 2026 to shareholders of record as of May 6, 2026.
The company will hold a conference call on May 1, 2026 at 8:00 a.m. CT to discuss first-quarter 2026 results; a live webcast and limited-time replay will be available on the investor website.
Aptar (NYSE: ATR) was named one of America’s Climate Leaders by USA Today for the fourth consecutive year on April 22, 2026. Aptar reports progress vs a 2019 baseline, SBTi-validated Scope 1 and 2 targets, CDP A List recognition, supplier engagement leadership, PPAs in Europe and the U.S.